Glutaredoxin2 reduces age-associated B cell differentiation through maintaining redox homeostasis

Area of Science:

• Immunology
• Redox Biology
• Autoimmune Diseases

Background:

• The redox system is crucial in autoimmune diseases and cancer.
• Age/autoimmunity-associated B cells (ABCs) have high reactive oxygen species (ROS) and are linked to systemic lupus erythematosus (SLE).
• The role of Glutaredoxin 2 (Grx2) in autoimmune B cell biology is not well understood.

Purpose of the Study:

• To investigate the role of Glutaredoxin 2 (Grx2) in regulating reactive oxygen species (ROS) and autoimmunity.
• To explore the mechanisms linking ROS to ABC differentiation.
• To assess Grx2 as a potential therapeutic target for SLE.

Main Methods:

• Compared ROS levels and ABC differentiation in wild-type and Grx2-knockout mice.
• Used in vitro methods to induce ABC differentiation and assess antioxidant effects (NAC).
• Utilized a lupus-prone mouse model (ShipΔB) crossed with Grx2 knockout mice.

Main Results:

• ABCs showed higher ROS than follicular B cells; NAC reduced ABC differentiation by 50%.
• Grx2 deficiency increased ROS and ABCs in aged mice, worsening autoimmunity.
• Grx2 deletion in lupus-prone mice heightened ABC differentiation, T cell activation, and autoantibodies.

Conclusions:

• Grx2 functions as a redox checkpoint, restricting ABC-driven autoimmunity by modulating ROS.
• The Grx2-ROS pathway is a promising therapeutic target for SLE and chronic inflammatory conditions.